Dr. Anthony Fauci, the director of the U.S. National Institute of Allergy and Infectious Diseases, told reporters on Wednesday that the drug Remdesivir helped improve outcomes for patients with COVID-19 in a clinical trial, and provided data suggesting it worked better when given earlier in the course of illness caused by the virus, but it still needs to be further analyzed. IN the same Oval Office meeting, U.S. President Donald Trump expressed optimism that the drug might provide an effective treatment for COVID-19.
Health
Coronavirus outbreak: Trump, Fauci hopeful about Gilead’s COVID-19 drug Remdesivir
More Videos
-
Health Matters: Caregiver report highlights need for help
-
Canada becomes 1st country to have individual cigarette warning labels
-
Anti-sunscreen claims circulating online spark criticism
-
Fact or fad? Decoding ‘Oatzempic,’ Liquid chlorophyll, and sugar substitutes
-
Health Matters: Norovirus spreading in Ontario, Alberta
-
Cancer survivor emphasizes importance of mental health care during diagnosis
You are viewing an Accelerated Mobile Webpage.
View Original Article